How earlier signals of misconnection may help pharma identify trust breakdowns before they show up as lagging measures in adherence, initiation, engagement, and outcomes.
|Articles|November 6, 2015
Elevating the Patient Voice: Leveraging Patients' Expertise to Advance Drug Development
Author(s)DIA
Advertisement
A report on progress with PDUFA V commitments to hold patient-focused drug development meetings; and on how patient focus is being built into 21st Century Cures legislation and forthcoming PDUFA VI reauthorization.
This article appeared in the August 2015 issue of
Advertisement
Related to this article
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech
2
Where GLP-1 Development May be Headed
3
Connecting RWD to Better Understand the Patient Journey
4
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
5